Advanced search
Publication Cover
Drug Delivery Volume 30, 2023 - Issue 1
Submit an article Journal homepage
1,599
Views
1
CrossRef citations to date
0
Altmetric
Research article

Negatively charged phospholipids doped liposome delivery system for mRNA with high transfection efficiency and low cytotoxicity

Lin Wanga State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Huanchun Xingb Tianjin University of Science and Technology, Tianjin, ChinaView further author information
,
Shuai Guoc Hebei University of Science and Technology, Shijiazhuang, ChinaView further author information
,
Wenbin Caoa State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Zinan Zhanga State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Lijuan Huanga State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Sui Xina State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Yuan Luoa State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaView further author information
,
Yongan Wanga State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Jun Yanga State Key Laboratory of Toxicology and Medical Countermeasures, Institutes of Pharmacology and Toxicology, Academy of Military Medical Sciences, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2219869 | Received 13 Feb 2023, Accepted 24 Apr 2023, Published online: 12 Jun 2023

References

  • Anthony K. (2022). RNA-based therapeutics for neurological diseases. RNA Biol 19:1–11.
  • Baeken MW, Yokobayashi Y. (2022). Identification of an ERN1 target site within EGFP mRNA. J Cell Biochem 123:1298–305.
  • Bogaert B, Sauvage F, Guagliardo R, et al. (2022). A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs. J Control Release 350:256–70.
  • Carrasco MJ, Alishetty S, Alameh MG, et al. (2021). Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun Biol 4:956.
  • Cheng X, Lee RJ. (2016). The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv Drug Deliv Rev 99:129–37.
  • Cheng Q, Wei T, Farbiak L, et al. (2020). Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol 15:313–20.
  • Clarke RJ. (2019). Effect of cholesterol on the dipole potential of lipid membranes. Adv Exp Med Biol 1115:135–54.
  • Durymanov M, Reineke J. (2018). Non-viral delivery of nucleic acids: insight into mechanisms of overcoming intracellular barriers. Front Pharmacol 9:971.
  • Eygeris Y, Gupta M, Kim J, Sahay G. (2022). Chemistry of lipid nanoparticles for RNA delivery. Acc Chem Res 55:2–12.
  • Forster Iii J, Nandi D, Kulkarni A. (2022). mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency. Biomater Sci 10:5566–82.
  • Koynova R, Tenchov B. (2011). Recent patents in cationic lipid carriers for delivery of nucleic acids. Recent Pat DNA Gene Seq 5:8–27.
  • Larson NR, Hu G, Wei Y, et al. (2022). pH-dependent phase behavior and stability of cationic lipid-mRNA nanoparticles. J Pharm Sci 111:690–8.
  • Leventis PA, Grinstein S. (2010). The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39:407–27.
  • Li M, Li Y, Li S, et al. (2022a). The nano delivery systems and applications of mRNA. Eur J Med Chem 227:113910.
  • Li N, Sun Y, Fu Y, Sun K. (2021). RNA drug delivery using biogenic nanovehicles for cancer therapy. Front Pharmacol 12:734443.
  • Liu S, Cheng Q, Wei T, et al. (2021). Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing. Nat Mater 20:701–10.
  • Li Y, Zhuang Q, Tao L, et al. (2022b). Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK/NF-κB pathway. Cell Prolif 55:e13291.
  • Luo J, Yang H, Song BL. (2020). Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol 21:225–45.
  • Lv H, Zhang S, Wang B, et al. (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 114:100–9.
  • Ramachandran S, Satapathy SR, Dutta T. (2022). Delivery strategies for mRNA vaccines. Pharmaceut Med 36:11–20.
  • Ruwizhi N, Aderibigbe BA. (2020). The efficacy of cholesterol-based carriers in drug delivery. Molecules 25:4330.
  • Schlake T, Thess A, Fotin-Mleczek M, Kallen KJ. (2012). Developing mRNA-vaccine technologies. RNA Biol 9:1319–30.
  • Seki H. (2018). Complications with vacuum delivery from a forceps-delivery perspective: Progress toward safe vacuum delivery. J Obstet Gynaecol Res 44:1347–54.
  • Simberg D, Weisman S, Talmon Y, Barenholz Y. (2004). DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 21:257–317.
  • Tenchov R, Bird R, Curtze AE, Zhou Q. (2021). Lipid nanoparticles─from liposomes to mrna vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15:16982–7015.
  • To KKW, Cho WCS. (2021). An overview of rational design of mRNA-based therapeutics and vaccines. Expert Opin Drug Discov 16:1307–17.
  • Webb C, Ip S, Bathula NV, et al. (2022). Current status and future perspectives on mRNA drug manufacturing. Mol Pharm 19:1047–58.
  • Yanez Arteta M, Kjellman T, Bartesaghi S, et al. (2018). Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc Natl Acad Sci U S A 115:E3351–E3360.
  • Zhang S, Xu Y, Wang B, et al. (2004). Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 100:165–80.
  • Zhao X, Ma X, Dupius JH, et al. (2022). Negatively charged phospholipids accelerate the membrane fusion activity of the plant-specific insert domain of an aspartic protease. J Biol Chem 298:101430.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.